KKR & Co said on Friday it would buy chemical maker Chase in an all-cash deal valued at about $1.3 billion including debt, to help the private equity firm bolster its holdings in the chemical specialty sector.
Under the deal terms, KKR will buy all outstanding shares of Chase common stock for $127.50 apiece.
Chase manufactures chemicals such as adhesives and coating materials to be used in industries ranging from automotive and electronics to energy markets.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Can’t stop reading? Read more
Top private equity news of the week
Top private equity news of the week Soho House, the global private members’ club and hotel group,...
Audax turns to Blackstone as Justrite seeks $700m private credit lifeline
Audax turns to Blackstone as Justrite seeks $700m private credit lifeline Audax Private Equity is...
Mitsubishi takes stake in RRJ-backed Fullerton Health to fuel Southeast Asia growth
Mitsubishi takes stake in RRJ-backed Fullerton Health to fuel Southeast Asia growth Mitsubishi...